DSE : IBP

Indo-Bangla Pharmaceuticals Limited — Reports

Pharmaceutical Preparations · Bangladesh

Last price 13.1 BDT (At close: Oct 29, 2026) · Market cap 1.52B

Latest research: Indo-Bangla Pharmaceuticals financial analysis: qualified FY2025 audit; FY2025 revenue 21.3% of FY2020 (Oct 2026) · Indo-Bangla Pharmaceuticals: revenue of BDT 184.2m in FY2025 against BDT 866.1m in FY2020, a qualified audit with a going-concern paragraph, and 9M FY2026 profit of BDT 2.8m

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Reports

36 annual and quarterly reports of Indo-Bangla Pharmaceuticals Limited (IBP) as PDF.